Skip to main content
main-content

Zeitschrift

Cancer and Metastasis Reviews

Cancer and Metastasis Reviews 4/2017

Ausgabe 4/2017

Special Issue: The Proteasome: An important player in tumor progression and a novel target for cancer therapy

Inhaltsverzeichnis ( 13 Artikel )

01.12.2017 | Ausgabe 4/2017

Biography—Q. Ping Dou

16.10.2017 | Ausgabe 4/2017

Preface

Q. Ping Dou

02.12.2017 | Ausgabe 4/2017

The proteasome and proteasome inhibitors in multiple myeloma

Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson, Paul G. Richardson

19.10.2017 | Ausgabe 4/2017

Emerging small molecule approaches to enhance the antimyeloma benefit of proteasome inhibitors

James J. Driscoll, Magen Brailey

25.10.2017 | Ausgabe 4/2017 Open Access

(Immuno)proteasomes as therapeutic target in acute leukemia

Jacqueline Cloos, Margot SF Roeten, Niels E Franke, Johan van Meerloo, Sonja Zweegman, Gertjan JL Kaspers, Gerrit Jansen

25.10.2017 | Ausgabe 4/2017

The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities

Wafik Zaky, Christa Manton, Claudia P. Miller, Soumen Khatua, Vidya Gopalakrishnan, Joya Chandra

14.11.2017 | Ausgabe 4/2017 Open Access

Proteasome-associated deubiquitinases and cancer

Arjan Mofers, Paola Pellegrini, Stig Linder, Pádraig D’Arcy

16.10.2017 | Ausgabe 4/2017 Open Access

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents

Xin Chen, Qianqian Yang, Lu Xiao, Daolin Tang, Q. Ping Dou, Jinbao Liu

27.10.2017 | Ausgabe 4/2017

Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications

Ying Fang, Xizhong Shen

17.10.2017 | Ausgabe 4/2017

E3 ubiquitin ligases in cancer and implications for therapies

Dong Wang, Leina Ma, Bin Wang, Jia Liu, Wenyi Wei

16.10.2017 | Ausgabe 4/2017

Proteasome dysregulation in human cancer: implications for clinical therapies

Yulin Chen, Yanan Zhang, Xing Guo

18.10.2017 | Ausgabe 4/2017

Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing

Claire L. Soave, Tracey Guerin, Jinbao Liu, Q. Ping Dou

16.10.2017 | NON-THEMATIC REVIEW | Ausgabe 4/2017

Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers

Lon Wolf R. Fong, David C. Yang, Ching-Hsien Chen

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise